Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Neurology
|
June 1, 1993
Central neurogenic mechanisms of migraine
K M Welch, G L Barkley, N Tepley, et al.
Neurology
|
May 1, 1994
The Henry Ford Hospital Headache Disability Inventory (HDI)
G P Jacobson, N M Ramadan, S K Aggarwal, et al.
Neurology
|
July 1, 1991
Scintillating scotomata associated with internal carotid artery dissection: report of three cases
N M Ramadan, G E Tietjen, S R Levine, et al.
Neurology
|
May 5, 1998
Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine
S K Aurora, B K Ahmad, K M Welch, et al.
Neurology
|
December 31, 1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group
G D Solomon, R K Cady, J A Klapper, et al.
Neurology
|
December 31, 1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group
A M Rapoport, N M Ramadan, J U Adelman, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Neurology
|
June 1, 1993
Central neurogenic mechanisms of migraine
K M Welch, G L Barkley, N Tepley, et al.
Neurology
|
May 1, 1994
The Henry Ford Hospital Headache Disability Inventory (HDI)
G P Jacobson, N M Ramadan, S K Aggarwal, et al.
Neurology
|
July 1, 1991
Scintillating scotomata associated with internal carotid artery dissection: report of three cases
N M Ramadan, G E Tietjen, S R Levine, et al.
Neurology
|
May 5, 1998
Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine
S K Aurora, B K Ahmad, K M Welch, et al.
Neurology
|
December 31, 1997
Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group
G D Solomon, R K Cady, J A Klapper, et al.
Neurology
|
December 31, 1997
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group
A M Rapoport, N M Ramadan, J U Adelman, et al.
Page
of 1